Invariant natural killer T cells play a pathogenic or a protective role in a minimal residual disease model of prostate cancer depending on their activation state
Invariant natural killer T cells play a pathogenic or a protective role in a minimal residual disease model of prostate cancer depending on their activation state
批准号:
347129
负责人:
Memarnejadian Arash
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-01-01 至 2017-01-01
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Every day, 73 Canadian men are diagnosed with and 11 die of prostate cancer (PCa). Treatment choices for PCa are limited, and chemotherapy and radiation often result in adverse and sometimes intolerable side effects. Anticancer immune cells are present in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文